Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Monday newspaper round-up: EV targets, Anthropic, Johnson & Johnson
(Sharecast News) - Britain's industrial sector is at risk of collapse as thousands of companies warn that they could face bankruptcy within the next year because of high energy prices, according to an industry survey. The manufacturers' body Make UK said the latest feedback from its members found that many would not be able to cope for much longer with energy costs that were twice the average in continental Europe and four times higher than in the US. - Guardian The UK government is poised to water down its 2030 targets for electric vehicle sales after intensive lobbying by the car industry and unions. The government is preparing to consult on less ambitious targets for the transition to fully battery-powered electric cars over the rest of the decade after carmakers and unions warned that they would penalise manufacturers and put jobs at risk. - Guardian
Rishi Sunak is believed to be among those unable to use Anthropic's most powerful AI models, despite his role as an adviser to the company. Anthropic has disabled access to Fable 5 and Mythos 5, its most advanced systems, under orders from the US department of commerce. It extends to Anthropic employees who are not US citizens. The company is also understood to have imposed restrictions on many of its US employees, not just on foreign citizens. - Telegraph
Johnson & Johnson has warned it may stop supplying free medicines under new early access schemes in Britain, in an escalation of an industry dispute with HM Revenue & Customs. The government is facing a backlash from drugs companies, charities and MPs over VAT bills for firms that provide medicines at no cost to patients through post-clinical trial continuity of care or compassionate use schemes. - The Times
Britain risks losing more high street shops and becoming a dumping ground for unsafe imports unless ministers move faster to close a tax loophole being exploited by overseas businesses, retailers have warned. Andrew Murphy, chief executive of The Entertainer, a toy shop chain with more than 150 stores, has expressed "grave concern and profound frustration" over plans to wait until 2029 before abolishing the £135 "de minimis" customs threshold. - The Times
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.